Discuss the role of ‘antibody-dependent enhancement’ in pathogenesis of severe dengue. Write in brief the laboratory diagnosis of dengue.
10 marks · directive: Discuss; Write
The core of a good answer
Infection with one of the four dengue serotypes is thought to give lifelong immunity to that serotype but only short-term protection against the others; in a later infection with a different serotype, antibodies bind the virus but fail to neutralise it and instead help it enter immune cells and reproduce (antibody-dependent enhancement), which is linked to severe dengue with plasma leakage, shock, low platelets and bleeding; laboratory diagnosis uses NS1 antigen and nucleic acid amplification in the first days and IgM antibodies from about day 4 to 5, with falling platelets and rising haematocrit as warning signs.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
Explain ADE as a step-by-step mechanism linking secondary infection to severe disease, with its vaccine implications, then describe tests by phase of illness.
Answer outline
Introduction
Dengue virus is a flavivirus with four serotypes (DENV-1 to DENV-4), spread mainly by female Aedes aegypti mosquitoes.
Antibody-dependent enhancement (ADE)
- Primary infection gives lifelong immunity to that serotype and only short-term cross-protection to others.
- In secondary infection with a different serotype, pre-existing antibodies bind the new virus but do not neutralise it.
- The antibody-virus complex enables the virus to infect target immune cells and reproduce, so viral replication increases; the mechanism of ADE is not fully understood.
- Increased capillary permeability lets plasma leak out of vessels.
- Result: severe dengue with plasma leakage (fluid in the lungs or abdomen), very low blood pressure and hypovolaemic shock, low platelets and bleeding; it can develop suddenly as the fever subsides.
- Vaccine implication: Dengvaxia should only be given to people previously infected with dengue; Qdenga can be given from age four, including to people not previously infected.
Laboratory diagnosis
- First few days of fever: NS1 antigen by ELISA (produced by all flaviviruses); nucleic acid amplification tests, the most reliable method.
- After about day 4 or 5: anti-dengue IgM can be reliably detected, but this does not determine the serotype.
- Supportive: decreasing platelets and increasing haematocrit are warning signs, together with dehydration and liver enlargement.
- Other flaviviruses (yellow fever, West Nile, Zika) are related, and NS1 is produced by all flaviviruses, which must be kept in mind when interpreting tests.
Conclusion
ADE explains why the second dengue infection is the dangerous one, and diagnosis must match the test to the day of illness.
Examples and data to cite
- Dengvaxia is recommended only for people with previous dengue infection.
- Qdenga is indicated for people aged four years and older and can be given to those not previously infected.
Facts to remember
- Dengue has four serotypes, DENV-1 to DENV-4.
- Nucleic acid amplification tests provide the most reliable method of diagnosis.
- Anti-dengue IgM can be reliably detected about four to five days into illness.
- Severe dengue involves plasma leakage, falling platelets and sometimes bleeding.